featured
Adjuvant Pembrolizumab vs Observation for Muscle-Invasive Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
N. Engl. J. Med 2024 Sep 15;[EPub Ahead of Print], AB Apolo, KV Ballman, G Sonpavde, S Berg, WY Kim, R Parikh, MY Teo, RF Sweis, DM Geynisman, P Grivas, G Chatta, ZR Reichert, JW Kim, MA Bilen, B McGregor, P Singh, A Tripathi, S Cole, N Simon, S Niglio, L Ley, L Cordes, S Srinivas, J Huang, M Odegaard, C Watt, D Petrylak, J Hoffman-Censits, Y Wen, O Hahn, C Mitchell, A Tan, H Streicher, E Sharon, H Moon, M Woods, S Halabi, G Perez Burbano, MJ Morris, JE RosenbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.